NCT01993745

The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 106 (actual)
• Sponsor: National Taiwan University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients

Detailed description

The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score \>25)

Conditions

• Cardiogenic Shock,
• With ECMO or IABP Support,
• With APACH II Score >25)

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-05-01
• Completion: 2009-12-01
• First posted: 2013-11-25
• Last updated: 2013-11-25

Locations

1 site across 1 country: Taiwan